Basawaraj Chickmath,Chandrashekar Giliyar,Nachiappan Chidambaram,Mahesh V. Patel,Srinivasan Venkateshwaran
申请号：
US15673293
公开号：
US20180125787A1
申请日:
2017.08.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure is drawn to pharmaceutical compositions and oral dosage forms containing testosterone undecanoate, as well as related methods of treatment. In one embodiment, the oral dosage form can include a therapeutically effective amount of testosterone undecanoate and a pharmaceutically acceptable carrier. The dosage form can be formulated such that, when measured using a USP Type II apparatus in 1000 mL of 8 wt % Triton X-100 in water at 37° C. and 100 rpm, the oral dosage form releases at least 20% more testosterone undecanoate after the first 120 minutes than an equivalent dose testosterone undecanoate containing oral dosage form without the pharmaceutically acceptable carrier.
